You are here

Global Spatiotemporal Disease Surveillance System

Award Information
Agency: Department of Defense
Branch: Office for Chemical and Biological Defense
Contract: W911NF-17-C-0063
Agency Tracking Number: C2-0472
Amount: $999,629.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: CBD13-102
Solicitation Number: 2013.1
Timeline
Solicitation Year: 2017
Award Year: 2017
Award Start Date (Proposal Award Date): 2017-08-23
Award End Date (Contract End Date): 2019-08-23
Small Business Information
8901 S La Cienega Blvd
Inglewood, CA 90301
United States
DUNS: 078274262
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 ONUR MUDANYALI
 DIRECTOR OF RESEARCH & DEVELOPMENT
 (310) 443-2070
 MUDANYALI@CELLMIC.COM
Business Contact
 Neven Karlovac
Phone: (310) 897-2096
Email: nkarlovac@cellmic.com
Research Institution
N/A
Abstract

We propose a high performance, cost-effective, universal Digital Assay Solutions platform with Mobile Readers, Assay Development and Calibration Software, and HIPAA-compliant cloud services for global health and defense applications. In Phase II project, we have developed the first generation product family receiving considerable interest from the assay manufacturers, government organizations and healthcare professionals with initial global sales. In this Sequential Phase II work, we outline a systematic work plan to significantly enhance the system design and performance (trans-visual sensitivity), lower the cost of the reader units (<$150), create modular mobile software for multi-use applications (e.g., personalized health and clinical studies), include multi-mode imaging capability and integrate the platform into the electronic health and laboratory information systems. The capability for wide area spatiotemporal disease surveillance developed in Phase II will be expanded for global applications in resource-limited environments. Furthermore, the new generation products will eliminate the need for the use of a dedicated smartphone device and work with any mobile device type and model (smartphone, tablet or personal computer) that runs our mobile application. The proposed platform offers a unique all-in-one solution to realize the potential of rapid assay technologies for personalized health, public health, national security and emergency services.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government